Macquarie assumed coverage on shares of Nutrien (NYSE:NTR) in a research note released on Friday, MarketBeat Ratings reports. The firm issued an outperform rating and a $59.00 price target on the stock.
Several other brokerages have also recently weighed in on NTR. Sanford C. Bernstein began coverage on Nutrien in a research report on Wednesday, January 3rd. They issued an outperform rating for the company. UBS Group reissued a buy rating on shares of Nutrien in a research note on Wednesday, January 3rd. Cowen reissued an outperform rating and set a $60.00 price objective on shares of Nutrien in a research note on Thursday. Finally, BMO Capital Markets began coverage on Nutrien in a research note on Wednesday, January 3rd. They set a market perform rating and a $54.00 price objective for the company. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and five have issued a buy rating to the company’s stock. Nutrien presently has an average rating of Hold and an average price target of $56.57.
Shares of Nutrien (NTR) traded down $1.89 during midday trading on Friday, hitting $53.84. The stock had a trading volume of 1,530,000 shares, compared to its average volume of 1,770,000. The stock has a market capitalization of $35,900.00 and a PE ratio of 40.53. Nutrien has a one year low of $51.81 and a one year high of $56.18. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.50 and a current ratio of 0.99.
COPYRIGHT VIOLATION NOTICE: “Macquarie Initiates Coverage on Nutrien (NTR)” was first reported by Community Financial News and is the sole property of of Community Financial News. If you are reading this story on another publication, it was copied illegally and reposted in violation of U.S. and international trademark and copyright law. The original version of this story can be read at https://www.com-unik.info/2018/01/08/macquarie-initiates-coverage-on-nutrien-ntr.html.
What are top analysts saying about Nutrien? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Nutrien and related companies.